Inactive Instrument
Precision Therapeutics Inc Stock Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 102M 90.79M 84.06M 76.07M 143M 9.61B 145M 1.01B 395M 5.05B 382M 374M 16.1B | P/E 2026 * |
-5.05x | P/E 2027 * | -79.9x |
|---|---|---|---|---|---|
| Enterprise Value | 102M 90.79M 84.06M 76.07M 143M 9.61B 145M 1.01B 395M 5.05B 382M 374M 16.1B | EV / Sales 2026 * |
1.69x | EV / Sales 2027 * | 0.24x |
| Free-Float |
93.93% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 2026-02-08 | |
| Director of Finance/CFO | - | 2026-04-15 | |
Kyle Okamoto
PSD | President | - | 2026-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 2020-02-18 |
Charles Nuzum
CHM | Chairman | 78 | 2026-02-08 |
| Director/Board Member | 60 | 2020-07-08 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 102M | ||
| -0.21% | -4.43% | +44.40% | +74.13% | 66.22B | ||
| +0.82% | +5.41% | +8.05% | +73.53% | 55.2B | ||
| -0.22% | +6.53% | +11.68% | +87.32% | 52.79B | ||
| +3.28% | +5.58% | +26.51% | +50.05% | 45.53B | ||
| +0.51% | +9.95% | +22.40% | +133.92% | 43.94B | ||
| -1.15% | +0.39% | +263.21% | +594.60% | 41.64B | ||
| +0.10% | +9.90% | +16.11% | +59.33% | 34B | ||
| -9.31% | -7.89% | +25.07% | -2.93% | 25.84B | ||
| +0.69% | +5.60% | +36.60% | +26.94% | 23.51B | ||
| Average | -1.30% | +4.07% | +50.45% | +121.88% | 43.19B | |
| Weighted average by Cap. | -0.20% | +3.72% | +49.42% | +126.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 60.4M 53.82M 49.83M 45.1M 84.96M 5.7B 85.97M 597M 234M 3B 227M 222M 9.55B | 431M 384M 356M 322M 607M 40.7B 614M 4.27B 1.67B 21.39B 1.62B 1.58B 68.17B |
| Net income | -41.4M -36.89M -34.16M -30.91M -58.23M -3.91B -58.92M -410M -161M -2.05B -155M -152M -6.54B | -4.5M -4.01M -3.71M -3.36M -6.33M -425M -6.4M -44.51M -17.47M -223M -16.88M -16.53M -711M |
| Net Debt | - | - |
Employees
-
















